MabVax Therapeutics Holdings, Inc. announced the appointment of Jeffrey Eisenberg to the board of directors. Jeffrey Eisenberg served in a variety of senior management positions, including most recently as President, Chief Executive Officer and a board member of Noven Pharmaceuticals, Inc.